Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 17, 2023
Reporting Period: Quarter ended June 30, 2023
Context: The Company issued a press release announcing preliminary financial results for the quarter ended June 30, 2023. This filing serves to disclose the issuance of that press release under Item 2.02.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document references a press release (Exhibit 99.1) containing these preliminary results but does not reproduce the data within the body of the 8-K text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms the announcement of preliminary results for the quarter ended June 30, 2023.
Guidance, Outlook, and Risks
Management Commentary: The filing notes the issuance of a press release regarding preliminary results but does not include specific management commentary, guidance, or outlook within the text provided.
Risks and Contingencies: No specific risks or contingencies are detailed in this excerpt. The filing includes a standard disclaimer that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be deemed incorporated by reference except as expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated July 17, 2023) for the actual preliminary financial figures for the quarter ended June 30, 2023.
- Verify the specific revenue, net income, and cash flow numbers once the full press release is accessed.
- Check for any forward-looking statements or guidance included in the attached press release.
- Confirm the status of the Company's securities registration, as the filing indicates "N/A" for trading symbols and exchanges.